Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,685 | 30,996 | 28,787 | 33,113 | 39,062 |
| TOTAL | $28,639 | $32,019 | $30,154 | $33,474 | $40,463 |
| Non-Current Assets | |||||
| PPE Net | 2 | 2 | 2 | 12 | 20 |
| Other Non-Current Assets | 40 | 0 | 0 | 136 | 200 |
| TOTAL | $42 | $2 | $2 | $148 | $221 |
| Total Assets | $28,681 | $32,020 | $30,156 | $33,622 | $40,684 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,131 | 826 | 843 | 1,136 | 3,990 |
| Accrued Expenses | 2,820 | 3,401 | 2,358 | 2,752 | 3,505 |
| TOTAL | $3,951 | $4,227 | $3,201 | $3,998 | $7,684 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,311 | 1,311 | 1,311 | 2,999 | 68,778 |
| TOTAL | $1,311 | $1,311 | $1,311 | $2,999 | $68,778 |
| Total Liabilities | $5,262 | $5,539 | $4,512 | $6,997 | $76,462 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,737 | 3,732 | 3,732 | 2,650 | 1,170 |
| Common Shares | 4 | 4 | 3 | 52 | 23 |
| Retained earnings | -301,435 | -298,176 | -293,796 | -291,354 | -287,330 |
| Other shareholders' equity | -10,635 | -10,561 | -10,623 | -10,241 | -10,267 |
| TOTAL | $23,419 | $26,482 | $25,644 | $26,625 | $-35,778 |
| Total Liabilities And Equity | $28,681 | $32,021 | $30,156 | $33,622 | $40,684 |